Board of Directors

Members of the Board of Directors are appointed by the Minister for Health and are responsible for setting the strategic direction of the service, appointing the Chief Executive Officer and overseeing the management of the service.

Powers and duties of the Board

Monash Health is a public health service pursuant to the Health Services Act 1988 (Vic) and:

  • is a body corporate with perpetual succession
  • may sue and be sued in its corporate name
  • is capable of purchasing, taking, holding, selling, leasing, taking on lease, exchanging and disposing of real and personal property
  • is capable of doing and suffering all acts and things which bodies corporate may by law do or suffer, and
  • the board has such powers as are necessary to enable it to carry out its function, including the power to make, amend or revoke by-laws.

The functions of the Board of Directors are:

  • to establish the objectives of the hospital
  • to establish the organisational structure of the hospital
  • to appoint a person to fill a vacancy in the position of Chief Executive Officer
  • to oversee the management of the hospital by the Chief Executive Officer
  • to develop plans, strategies and budgets to ensure the provision of health services by the hospital and the long term financial viability of the hospital
  • to monitor the performance of the hospital, and
  • to monitor the performance of the Chief Executive Officer of the hospital.

Board of Directors

Mr Dipak Sanghvi

Mr Dipak Sanghvi

BSc Pharm (UK), FAICD, FAIPM

Chair of the Monash Health Board
Chair, Remuneration Committee
Chair, Aboriginal Health Strategic Partnership Committee
Member, Finance Committee
Term of appointment: December 2015 – current

Dipak Sanghvi is a pharmacist who owns five pharmacies in Victoria. Currently, he is Chair of Member Benefits Australia Pty Ltd and Chair of Musculoskeletal Australia. His previous positions include President of the Pharmacy Guild Victoria Branch during 2006-2011, Chair of Gold Cross Products and Services Pty Ltd, Chair of Return of Unwanted Medicines, a Board member of Guild Insurance and Superannuation and Meridian Lawyers. He also holds several board positions in the community and pharmaceutical industry.

Mr Charles Gillies

Mr Charles Gillies

BSc/BA, MBA, SF Fin, GAICD

Chair, Finance Committee
Member, Remuneration Committee
Term of appointment: July 2011 – current

Charles Gillies is co-founder of Jolimont Global Mining Systems which specialises in investing in mining technology companies. As an active investor, Mr Gillies’ approach has been to work closely with management to develop a plan to create economic value. He has been Director and Chairman of a number of technology and investment companies and has worked closely with CEOs and management teams to develop strategies and set objectives and performance targets.

Dr Misty Jenkins

Dr Misty Jenkins

BSc (Hons), PhDm MAICD

Member, Quality Committee
Member, Aboriginal Health Strategic Partnership Committee
Term of appointment: November 2016 – current

Dr Misty Jenkins is a NHMRC fellow, biomedical scientist and laboratory head at Walter and Eliza Hall Institute for Medical Research, where she researches cellular immunology and new immunotherapies for cancer. She previously held postdoctoral positions at The Universities of Cambridge and Oxford, and The Peter MacCallum Cancer Centre in Melbourne. For her achievements, she was awarded the L’Oreal for Women in Science Fellowship (2013), was Tall Poppy of the year (2015) and won the Westpac/Australian Financial Review Top100 Women of Influence award (2016). In addition to her research career, Dr Jenkins brings experience in governance as a Director and Deputy Chair of The National Centre for Indigenous Genomics at ANU, previous Director of the Aurora Education Foundation, Ambassador for the Poche Centre for Indigenous Health and Chair of NHMRC Project Grant Review Panels.

Emeritus Professor Hatem Salem AM

Emeritus Professor Hatem Salem AM

MB, ChB (Mosul, Iraq), FRACP, FRCPA, MRCP (UK) MD (Monash), LRCP, MRCS.

Chair, Quality Committee
Member, Remuneration Committee
Term of appointment: May 2017 – current

Professor Hatem Salem is an Emeritus Professor at Monash University. Prior to this, Professor Salem was the Head of the Academic Department of Clinical Haematology at Monash University and the Head of Clinical Haematology at the Alfred Hospital. He served as President of Asia Pacific Society of Thrombosis and Haemostasis and past president and Executive Director of the Australasian Society of Thrombosis and Hemostasis. He is a senior Counsellor of the International Society of Thrombosis and Hemostasis. In 2005, his vision and ability to develop leading clinical and research programs was recognised by the Victorian Government’s Public Healthcare Award, where he was the recipient of the Health Minister’s Award for Outstanding Individual Achievement. In 2010, Professor Hatem Salem was awarded the Member of the Order of Australia (AM) for service to medicine in the field of haematology as a clinician, educator and researcher and also through the establishment of the Australian Centre for Blood Diseases.

Mrs Jane Bell

Mrs Jane Bell

BEc, LLB, LLM (Lond), FAICD

Chair, Audit Committee
Director, Kitaya Holdings Board Pty Ltd*
Term of appointment: July 2018 – current

Jane Bell is a banking and finance lawyer and non-executive director with more than 30 years’ experience in leading law firms, financial services, corporate treasury operations and governance gained living in Melbourne, London, Toronto, San Francisco and Brisbane. She has been a non-executive director since 2002, serving on 11 Boards including eight health sector and medical research institute Boards. Currently, Mrs Bell serves as Deputy Chair of Biomedical Research Victoria, Director of UCA Funds Management Limited and as Chair of the Community Advisory Group of the Melbourne Genomics Health Alliance. She is also a Member of the Administrative Appeals Tribunal. Mrs Bell is a former Board member of Melbourne Health (Royal Melbourne Hospital), WorkSafe Victoria, Hudson Institute of Medical Research-Monash Institute of Medical Research-Prince Henry’s Institute of Medical Research, Queensland Institute of Medical Research Trust, Victorian Women’s Housing Association, Australian Red Cross (Qld) and Deputy Chair of Westernport Water Corporation.

*Kitaya Holdings Pty Ltd operates Jessie McPherson Private Hospital

Ms Aurelia Balpe

Ms Aurélia Balpe

MBA, GAICD, GradDip Demog, BEc

Chair, Primary Care and Population Health Advisory Committee
Member, Quality Committee
Term of appointment: July 2018 – current
 

Aurélia Balpe is an international humanitarian leader with experience in the non-profit and for-profit sectors in Asia, the Pacific, the Americas, Africa and Europe. Previously, she worked with boards and senior executive teams on the development of strategy and policy, legal compliance, risk management, organisational performance and the resolution of integrity issues. Ms Balpe has had oversight of multi-national programmes in organisational development, disaster response and law, water and sanitation and health. She has also been a strategic advisor to governments, United Nations agencies, regional organisations and corporations on humanitarian action and coordination. Currently, she serves as a member of the Australian Red Cross Divisional Advisory Board. She was awarded the Vanuatu Red Cross medal in 2015 for her contribution to the Tropical Cyclone Pam Relief Operation and was the recipient of the Monash University Top Achievement and Dean’s Awards for her MBA in 2017. Ms Balpe is currently undertaking a Graduate Diploma in Psychology.

Ms Helen Brunt

Ms Helen Brunt

BA (Hons), GAICD

Member, Finance Committee
Term of appointment: July 2019 – current

Helen Brunt is a senior governance and technology delivery executive who brings extensive experience in digital technology and large scale transformation in complex business environments including Wesfarmers and Westpac. She is skilled in developing strategies to leverage technology to support business strategy. Ms Brunt is passionate about diversity and the use of technology to transform customer and employees experience and previously served as an associate board member for the VIC ICT for Women in IT. Currently, she is an elected Member Director of the Wesfarmers Super Trust Policy Committee.

Mr Tony Brain

Mr Tony Brain

BCom, CA, FAIST, GAICD

Member, Audit Committee
Member, Finance Committee
Term of appointment: July 2019 – current

Tony Brain is a Chartered Accountant with over 30 years’ experience in governance, assurance, finance and regulatory oversight. His Tony’s executive leadership experience includes 12 years as Partner at Deloitte and nearly 3 years as Head of Risk Management at Australian Super. In addition to Monash Health, his current Non-Executive Director experience includes 3 years at the Australian Scholarships Group Friendly Society Pty Ltd and nearly 1 year at AMP Superannuation Limited where he is currently in the role as Interim Chair. Mr Brain also sits on various Board Committees for Victoria University, Barwon Health, Magistrates Court Victoria and the Alannah and Madeline Foundation. He is also a current member of the Companies Auditor Disciplinary Board.

Robyn McLeod

Ms Robyn McLeod

BA, BEd, GAICD

Member, Audit Committee
Member, Community Advisory Committee
Member, Primary Care and Population Health Advisory Committee
Term of appointment: July 2019 – current

Robyn McLeod is a governance and public policy expert who currently serves on the Boards of Melbourne Water and VicWater, and previously served as a member of the Governance working group of the Board of Good Shepherd Australia and New Zealand. Her previous positions include director of the Australian Centre for Social Innovation, Independent Commissioner for Water Security in South Australia, National Director of Water for KPMG, Executive Director of Major Projects Water with the Department of Sustainability and Environment, Victoria and Chief of Staff to the Victorian Energy Resources and Ports Minister.

Stay informed with the latest updates on coronavirus (COVID-19).Find out more
+